Accueil   Diary - News   All news BIOASTER and Pherecydes Pharma join forces to explore the use of phage therapy

BIOASTER and Pherecydes Pharma join forces to explore the use of phage therapy

 

July 9th, 2019 - BIOASTER, the French Technology Research Institute (TRI) for Microbiology and Infectious Diseases, announced today the signature of a collaboration agreement with Pherecydes Pharma, a French Biotechnology company, with the objective of discovering lytic bacteriophages, to be developed into a pharmaceutical solution to treat bacterial infections including those caused by multidrug resistant strains.

 

Read the press release